RLAY
Relay Therapeutics, Inc. · Healthcare
Chief Financial Officer Thomas Catinazzo sold $3.2M of Relay Therapeutics, Inc.
Sold$3,176,865
$16.97Price
187,163Shares
−51%Stake
What RLAY did after the filing
- The stock from Thu, Jun 25 open, $18.09
- +9.3%
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Aug 7 close.
Traded Mon, Jun 22. Filed Wed, Jun 24, 4:09 PM ET, after the close. Returns use the Jun 25 open and the Aug 7 close. Not investment advice.